AVILEX PHARMA ApS: Financial statements 2021
CVR: 34896828
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
AVILEX PHARMA ApS (CVR 34896828) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -6,611,177 compared with DKK -3,041,705 the year before. Equity in the 2021 report amounted to DKK -25,260,470. The company had 2 employees in the financial year.
- Profit/Loss
- DKK -6,611,177
- Equity
- DKK -25,260,470
- Total Assets
- DKK 4,916,599
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | -6.6 mio. | -25.3 mio. | 2 |
| 2020 | - | -3.1 mio. | -3 mio. | -18.6 mio. | 2 |
| 2019 | - | - | -3.7 mio. | -15.6 mio. | 4 |
| 2018 | - | - | -3.9 mio. | -11.9 mio. | 1 |
| 2017 | - | - | -2.4 mio. | -8.1 mio. | 1 |
Official annual report
Find more companies like AVILEX PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
AVILEX PHARMA ApS has published its annual report for 2020. Gross profit came to DKK -3,132,649, and the net result was DKK -3,041,705.
About AVILEX PHARMA ApS
AVILEX PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Strømgaard. The board consists of Raymond George Hill (chair), Camilla Petrycer Hansen, Jonathan Mark Treherne and Kristian Strømgaard. The company's owners include Novo Holdings A/S, MIKAEL SØNDERGÅRD THOMSEN ApS and KRISTIAN STRØMGAARD HOLDING ApS. The company has 4 employees (2025). In 2025, the company reported a net result of DKK -4,530,000 compared with DKK -4,428,000 the year before. Equity in the 2025 report amounted to DKK -10,797,000.